545 related articles for article (PubMed ID: 22926518)
21. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
[TBL] [Abstract][Full Text] [Related]
22. TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling.
Fattet L; Ay AS; Bonneau B; Jallades L; Mikaelian I; Treilleux I; Gillet G; Hesling C; Rimokh R
J Cell Sci; 2013 Aug; 126(Pt 16):3713-23. PubMed ID: 23788427
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
[TBL] [Abstract][Full Text] [Related]
24. An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling.
Ikushima H; Komuro A; Isogaya K; Shinozaki M; Hellman U; Miyazawa K; Miyazono K
EMBO J; 2008 Nov; 27(22):2955-65. PubMed ID: 18923419
[TBL] [Abstract][Full Text] [Related]
25. Non-Smad signaling pathways.
Mu Y; Gudey SK; Landström M
Cell Tissue Res; 2012 Jan; 347(1):11-20. PubMed ID: 21701805
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation.
Verrecchia F; Pessah M; Atfi A; Mauviel A
J Biol Chem; 2000 Sep; 275(39):30226-31. PubMed ID: 10903323
[TBL] [Abstract][Full Text] [Related]
27. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
Buck MB; Pfizenmaier K; Knabbe C
Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
[TBL] [Abstract][Full Text] [Related]
28. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
Palcy S; Bolivar I; Goltzman D
J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
[TBL] [Abstract][Full Text] [Related]
29. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
31. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
32. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.
Dennler S; Huet S; Gauthier JM
Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636
[TBL] [Abstract][Full Text] [Related]
33. Role of activator protein-1 on the effect of arginine-glycine-aspartic acid containing peptides on transforming growth factor-beta1 promoter activity.
Ruiz-Torres MP; Perez-Rivero G; Diez-Marques ML; Griera M; Ortega R; Rodriguez-Puyol M; Rodríguez-Puyol D
Int J Biochem Cell Biol; 2007; 39(1):133-45. PubMed ID: 16978906
[TBL] [Abstract][Full Text] [Related]
34. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation.
Robinson CM; Prime SS; Huntley S; Stone AM; Davies M; Eveson JW; Paterson IC
Int J Cancer; 2001 Mar; 91(5):625-30. PubMed ID: 11267971
[TBL] [Abstract][Full Text] [Related]
36. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
Tacheau C; Fontaine J; Loy J; Mauviel A; Verrecchia F
J Cell Physiol; 2008 Dec; 217(3):759-68. PubMed ID: 18668519
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
39. Role of Smads in TGFβ signaling.
Heldin CH; Moustakas A
Cell Tissue Res; 2012 Jan; 347(1):21-36. PubMed ID: 21643690
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
Goumans MJ; Mummery C
Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
